SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001104659-20-086007
Filing Date
2020-07-23
Accepted
2020-07-23 16:43:32
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 17905
2 GRAPHIC image_001.jpg GRAPHIC 12947
3 GRAPHIC image_002.jpg GRAPHIC 10036
  Complete submission text file 0001104659-20-086007.txt   50757
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)